Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP (2008) Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 143(3):336–348
Noris M, Remuzzi G (2009) Atypical hemolytic–uremic syndrome. N Engl J Med 361:1676–1687
Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship THJ et al (2008) Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood 111(2):624–632
Fakhouri F, Jablonski M, Lepercq J, Blouin J, Benachi A, Hourmant M et al (2008) Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood 112(12):4542–4545
Kavanagh D, Anderson HE (2012) Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome. Kidney Int 81(1):11–13
Haram K (2009) The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 9:8
Sibai BM (2009) Imitators of severe pre-eclampsia. Semin Perinatol 33(3):10
Lynch AMA, Salmon JEJ (2010) Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta 31(7):7
Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050
Fremeaux-Bacchi V (2012) Treatment of atypical uraemic syndrome in the era of eculizumab. Clin Kidney J 5(1):4–6